Profile
| Metric | Value |
|---|---|
| Full Name | Ventyx Biosciences, Inc. |
| Ticker | NASDAQ: VTYX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | ventyxbio.com |
| Employees | 81 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $13.81 | |
| Price, 1D Change | +37.41% | |
| Market Cap | $985M | |
| - | ||
| PE Ratio | - | |
| Beta | 1.60 | |
| Revenue | $0 | |
| Revenue, 1Y Change | 0.00% | |
| EPS | -$1.97 | |
| EPS, 1Y Change | +40.14% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$1.97 | |
| EPS Estimate | -$1.44 | |
| EPS Est. Change | +26.80% | |
| Revenue | $0.00 | |
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| Current Price | $13.81 | |
| Price Target | - | $14.00 |
| Price Tgt. Change | - | +1.38% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.45 | -$3.30 | +4.46% | |
| -$2.10 | -$1.97 | +5.91% | |
| -$1.44 | N/A | +26.80% | |
| -$1.61 | N/A | +18.62% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +448.02% | |
| Price, 3Y | -57.08% | |
| Market Cap, 1Y | +449.78% | |
| Market Cap, 3Y | -46.26% | |
| Revenue, 1Y | 0.00% | |
| Revenue, 3Y | 0.00% | |
| EPS, 1Y | +40.14% | |
| EPS, 3Y | -16.61% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $13.81 | |
| SMA 200 | $3.92 | |
| SMA 200 vs Price | -71.65% | |
| SMA 50 | $8.75 | |
| SMA 50 vs Price | -36.61% | |
| Beta | 1.60 | |
| ATR | $1.86 | |
| 14-Day RSI | 60.69 | |
| 10-Day Volatility | 164.03% | |
| 1-Year Volatility | 122.41% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $0.00 | |
| EPS | -$1.97 | |
| Gross Profit | -$1.35M | |
| - | ||
| Operating Profit | -$148.45M | |
| - | ||
| Net Income | -$135.12M | |
| - | ||
| EBITDA | -$147.10M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.04 | |
| 17.97 | ||
| 17.97 | ||
| - | ||
| - | ||
| 20.40 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| - | ||
| 5.15 | ||
| -6.98 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $254.05M | |
| $27.26M | ||
| $278.67M | ||
| $229.63M | ||
| $24.62M | ||
| $12.78M | ||
| Total Debt | $10.79M | |
| $1.05M | ||
| $3.13M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $148.45M | ||
| $148.45M | ||
| $1.35M | ||
| $31.45M | ||
| $1.35M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$130.87M | ||
| -$15.51M | ||
| $122.12M | ||
| Capex | $241.00K | |
| -$131.11M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wells Fargo | → | |
| Canaccord Genuity | → | |
| HC Wainwright & Co. | → | |
| Oppenheimer | → | |
| Clear Street | ||
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Oppenheimer | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with VTYX
Data Sources & References
- VTYX Official Website ventyxbio.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1851194/000119312525269517/0001193125-25-269517-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1851194/000095017025029245/0000950170-25-029245-index.htm
- VTYX Profile on Yahoo Finance finance.yahoo.com/quote/VTYX
- VTYX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vtyx
FAQ
What is the ticker symbol for Ventyx Biosciences, Inc.?
The ticker symbol for Ventyx Biosciences, Inc. is NASDAQ:VTYX
Does Ventyx Biosciences, Inc. pay dividends?
No, Ventyx Biosciences, Inc. does not pay dividends
What sector is Ventyx Biosciences, Inc. in?
Ventyx Biosciences, Inc. is in the Healthcare sector
What industry is Ventyx Biosciences, Inc. in?
Ventyx Biosciences, Inc. is in the Biotechnology industry
What country is Ventyx Biosciences, Inc. based in?
Ventyx Biosciences, Inc. is headquartered in United States
When did Ventyx Biosciences, Inc. go public?
Ventyx Biosciences, Inc. initial public offering (IPO) was on October 21, 2021
Is Ventyx Biosciences, Inc. in the S&P 500?
No, Ventyx Biosciences, Inc. is not included in the S&P 500 index
Is Ventyx Biosciences, Inc. in the NASDAQ 100?
No, Ventyx Biosciences, Inc. is not included in the NASDAQ 100 index
Is Ventyx Biosciences, Inc. in the Dow Jones?
No, Ventyx Biosciences, Inc. is not included in the Dow Jones index
When was Ventyx Biosciences, Inc. last earnings report?
Ventyx Biosciences, Inc.'s most recent earnings report was on November 6, 2025
When does Ventyx Biosciences, Inc. report earnings?
The next expected earnings date for Ventyx Biosciences, Inc. is February 26, 2026